Acutus Medical Stock News

Some of the stocks that may grab investor focus today are: Wall Street expects Walgreens Boots Alliance, Inc. (NASDAQ: WBA) to report quarterly earnings at $1.38 per share on revenue of $33.36 bill

AFIB earnings call for the period ending December 31, 2021.

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of -8.70% and 1.44%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Acutus Medical, Inc. (AFIB) CEO Vince Burgess on Q4 2021 Results - Earnings Call Transcript

CARLSBAD, Calif., March 30, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac ar

Acutus Medical, Inc. (AFIB) delivered earnings and revenue surprises of -8.70% and 1.44%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

CARLSBAD, Calif., March 17, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac ar

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus AbbVie's Rinvoq Gets Label Expansion To Treat Ulcerative Colitis AbbVie, Inc. (NYSE: ABBV) announced 

CARLSBAD, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnos

CARLSBAD, Calif., March 10, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus”) (Nasdaq: AFIB), an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed

The Cooper Companies (COO) delivered earnings and revenue surprises of 5.19% and 6.84%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?

SAN DIEGO, March 03, 2022 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announced that it has filed a class action lawsuit seeking to represent purchasers of Acutus Medical, Inc. (NASDAQ: AFIB) common stock between May 13, 2021 and November 11, 2021, both dates inclusive (the “Class Period”) and charging Acutus Medical and certain of its top executives with violations of the Securities Exchange Act of 1934. The Acutus Medical class action lawsuit – captioned Brown v. Acutus Medical, Inc. , No. 22-cv-00206 (S.D. Cal.) – was filed on February 15, 2022 and is assigned to Judge Jinsook Ohta.

NEW YORK, March 3, 2022 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Acutus Medical, Inc. ("Acutus" or the "Company") (NASDAQ: AFIB) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Acutus investors who were adversely…

Shareholder Action Reminder: The Schall Law Firm Encourages Investors in Acutus Medical, Inc. with Losses of $100,000 to Contact the Firm

NEW YORK, March 01, 2022 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP ( www.kaplanfox.com ) is investigating claims on behalf of investors of Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB). A complaint has been filed on behalf of investors who purchased or otherwise acquired Acutus common stock between May 13, 2021 and November 11, 2021, inclusive (the “Class Period”).